The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6387729 7150975 I 6387729-3 19960507 20090918 20090930 EXP GXBR2009US01850 SANDOZ INC. 30 YR M N 20090928 MD 19960510 UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6387729 1012374767 PS AMPICILLIN 1 61395
6387729 1012432195 SS SULFADIAZINE 1 25 MG, Q8H D D
6387729 1012432196 SS HYDROXYZINE HCL 1 MG, PRN D D
6387729 1012432197 SS METHADONE HYDROCHLORIDE 1 40 MG, QD D D
6387729 1012432198 SS FOLIC ACID 1 5 MG, OD
6387729 1012432199 SS CEFTRIAXONE 1 D D
6387729 1012432200 SS INVIRASE 1 ORAL 600 MG, TID, ORAL D D
6387729 1012432201 SS VERSED 1 D D
6387729 1012432202 SS TRIMETHOPRIM 1 D D
6387729 1012432249 SS AZT 1 200 MG, Q8H D D
6387729 1012432265 SS LAMIVUDINE 1 150 MG, Q12H D D
6387729 1012432266 SS DILANTIN 1 200 MG Q12H D D
6387729 1012432267 SS ETHAMBUTOL (ETHAMBUTOL) 2 150 MG, QD2SDO D D
6387729 1012432268 SS PYRIMETHAMINE TAB 1 25 MG, Q8H D D
6387729 1012432269 SS ATIVAN 1 D D
6387729 1012432270 SS HALDOL 1 D D
6387729 1012432271 SS PEPCID 1 D D
6387729 1012432272 SS CLINDAMYCIN HCL 1 D D
6387729 1012432283 SS ACYCLOVIR 1 D D
6387729 1012432285 SS MANNITOL 1 N D
6387729 1012432288 SS MORPHINE 1 D D
6387729 1012432291 SS COCAINE (COCAINE) 2 D D

Indications of drugs used

Event ID DRUG SEQ INDI PT
6387729 1012374767 OPPORTUNISTIC INFECTION PROPHYLAXIS
6387729 1012432199 OPPORTUNISTIC INFECTION PROPHYLAXIS
6387729 1012432200 HIV INFECTION
6387729 1012432201 AGITATION
6387729 1012432202 PROPHYLAXIS
6387729 1012432249 ANTIRETROVIRAL THERAPY
6387729 1012432265 ANTIRETROVIRAL THERAPY
6387729 1012432267 OPPORTUNISTIC INFECTION PROPHYLAXIS
6387729 1012432269 AGITATION
6387729 1012432270 AGITATION
6387729 1012432283 ANTIVIRAL PROPHYLAXIS

Outcome of event

Event ID OUTC COD
6387729 DE
6387729 HO

Reactions reported

Event ID PT
6387729 AGITATION
6387729 ATAXIA
6387729 BLOOD CREATINE PHOSPHOKINASE INCREASED
6387729 BLOOD MAGNESIUM DECREASED
6387729 BLOOD PHOSPHORUS DECREASED
6387729 BLOOD POTASSIUM DECREASED
6387729 CACHEXIA
6387729 DRUG SCREEN POSITIVE
6387729 DYSKINESIA
6387729 ELECTROCARDIOGRAM QT PROLONGED
6387729 ENCEPHALITIS HERPES
6387729 HEADACHE
6387729 HYPOTENSION
6387729 LISTERIOSIS
6387729 MENTAL STATUS CHANGES
6387729 MUSCLE TWITCHING
6387729 MUSCULAR WEAKNESS
6387729 NO THERAPEUTIC RESPONSE
6387729 PARAPARESIS
6387729 PUPILS UNEQUAL
6387729 SPEECH DISORDER
6387729 TORSADE DE POINTES
6387729 VENTRICULAR EXTRASYSTOLES

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
6387729 HP

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6387729 1012374767 19960508
6387729 1012432199 19960508
6387729 1012432200 19960501 3 DAY
6387729 1012432201 19960508
6387729 1012432269 19960508
6387729 1012432270 19960508
6387729 1012432271 19960508
6387729 1012432272 19960508
6387729 1012432283 19960508
6387729 1012432285 19960508
6387729 1012432288 19960509